SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-061423
Filing Date
2023-03-06
Accepted
2023-03-06 16:21:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d261948d424b5.htm 424B5 452208
2 GRAPHIC g261948g06j65.jpg GRAPHIC 41652
3 GRAPHIC g261948g18y15.jpg GRAPHIC 35879
  Complete submission text file 0001193125-23-061423.txt   556164
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260970 | Film No.: 23709209
SIC: 2836 Biological Products, (No Diagnostic Substances)